MAUNA KEA TECHNOLOGIES (ALMKT.PA) Fundamental Analysis & Valuation

EPA:ALMKT • FR0010609263

Current stock price

0.1616 EUR
-0.01 (-3.35%)
Last:

This ALMKT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALMKT.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALMKT has reported negative net income.
  • ALMKT had a negative operating cash flow in the past year.
  • In the past 5 years ALMKT always reported negative net income.
  • ALMKT had a negative operating cash flow in each of the past 5 years.
ALMKT.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -82.18%, ALMKT is doing worse than 90.32% of the companies in the same industry.
Industry RankSector Rank
ROA -82.18%
ROE N/A
ROIC N/A
ROA(3y)-45.6%
ROA(5y)-50.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMKT.PA Yearly ROA, ROE, ROICALMKT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

  • With a Gross Margin value of 31.67%, ALMKT is not doing good in the industry: 83.87% of the companies in the same industry are doing better.
  • ALMKT's Gross Margin has improved in the last couple of years.
  • ALMKT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
ALMKT.PA Yearly Profit, Operating, Gross MarginsALMKT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. ALMKT.PA Health Analysis

2.1 Basic Checks

  • ALMKT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALMKT has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ALMKT has more shares outstanding
  • ALMKT has a worse debt/assets ratio than last year.
ALMKT.PA Yearly Shares OutstandingALMKT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALMKT.PA Yearly Total Debt VS Total AssetsALMKT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -7.59, we must say that ALMKT is in the distress zone and has some risk of bankruptcy.
  • ALMKT has a Altman-Z score of -7.59. This is amonst the worse of the industry: ALMKT underperforms 90.32% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.59
ROIC/WACCN/A
WACC6.75%
ALMKT.PA Yearly LT Debt VS Equity VS FCFALMKT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

  • ALMKT has a Current Ratio of 0.23. This is a bad value and indicates that ALMKT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.23, ALMKT is not doing good in the industry: 91.94% of the companies in the same industry are doing better.
  • ALMKT has a Quick Ratio of 0.23. This is a bad value and indicates that ALMKT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALMKT's Quick ratio of 0.12 is on the low side compared to the rest of the industry. ALMKT is outperformed by 95.16% of its industry peers.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.12
ALMKT.PA Yearly Current Assets VS Current LiabilitesALMKT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ALMKT.PA Growth Analysis

3.1 Past

  • ALMKT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -114.81%.
  • Looking at the last year, ALMKT shows a very negative growth in Revenue. The Revenue has decreased by -26.96% in the last year.
  • The Revenue has been growing slightly by 0.60% on average over the past years.
EPS 1Y (TTM)-114.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.27%
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%-4.62%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.86% on average over the next years. This is a very strong growth
  • ALMKT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.29% yearly.
EPS Next Y50%
EPS Next 2Y61.25%
EPS Next 3Y23.86%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y19.76%
Revenue Next 3Y19.29%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALMKT.PA Yearly Revenue VS EstimatesALMKT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
ALMKT.PA Yearly EPS VS EstimatesALMKT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALMKT.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALMKT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 2.61, the valuation of ALMKT can be described as very cheap.
  • 98.39% of the companies in the same industry are more expensive than ALMKT, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. ALMKT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 2.61
ALMKT.PA Price Earnings VS Forward Price EarningsALMKT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMKT.PA Per share dataALMKT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1 -0.15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALMKT's earnings are expected to grow with 23.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.25%
EPS Next 3Y23.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALMKT.PA Dividend Analysis

5.1 Amount

  • ALMKT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALMKT.PA Fundamentals: All Metrics, Ratios and Statistics

MAUNA KEA TECHNOLOGIES

EPA:ALMKT (3/27/2026, 7:00:00 PM)

0.1616

-0.01 (-3.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-02
Earnings (Next)04-09
Inst Owners5.63%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap31.04M
Revenue(TTM)7.66M
Net Income(TTM)-10.40M
Analysts86
Price Target0.36 (122.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-30%
PT rev (3m)-30%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.61
P/S 4.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)0.06
Fwd EY38.24%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.04
BVpS-0.15
TBVpS-0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -82.18%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.67%
FCFM N/A
ROA(3y)-45.6%
ROA(5y)-50.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
F-Score3
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.33%
Cap/Sales 3.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.12
Altman-Z -7.59
F-Score3
WACC6.75%
ROIC/WACCN/A
Cap/Depr(3y)16.65%
Cap/Depr(5y)36.4%
Cap/Sales(3y)2.78%
Cap/Sales(5y)7.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-114.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.27%
EPS Next Y50%
EPS Next 2Y61.25%
EPS Next 3Y23.86%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%-4.62%
Revenue Next Year0%
Revenue Next 2Y19.76%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y-594.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year7.14%
EBIT Next 3Y23.7%
EBIT Next 5YN/A
FCF growth 1Y-3920%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2465%
OCF growth 3YN/A
OCF growth 5YN/A

MAUNA KEA TECHNOLOGIES / ALMKT.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALMKT.PA.


What is the valuation status of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to MAUNA KEA TECHNOLOGIES (ALMKT.PA). This can be considered as Fairly Valued.


How profitable is MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?

MAUNA KEA TECHNOLOGIES (ALMKT.PA) has a profitability rating of 1 / 10.


What is the financial health of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?

The financial health rating of MAUNA KEA TECHNOLOGIES (ALMKT.PA) is 0 / 10.